Structural elucidation of full-length Pfs48/45 in complex with potent mAbs isolated from a naturally exposed individual

Author:

Julien Jean-Philippe1ORCID,Kucharska Iga1,Ivanochko Danton1,Hailemariam Sophia1,Inklaar Maartje2,Kim Hee Ryung1,Teelen Karina2,Stoter Rianne2,de Vegte-Bolmer Marga van2,Gemert Geert-Jan van2,Semesi Anthony1,McLeod Brandon1,Ki Ahyoung3,Lee Won-Kyu3ORCID,Rubinstein John4ORCID,Jore Matthijs2

Affiliation:

1. The Hospital for Sick Children Research Institute

2. Radboud University Medical Center

3. KBIO Osong Medical Innovation Foundation

4. The Hospital for Sick Children

Abstract

Abstract Biomedical interventions capable of preventing the transmission of malaria-causing Plasmodium falciparum (Pf) between the human host and mosquito vector could prove a valuable tool in malaria elimination efforts. Pfs48/45, a gamete-surface protein essential for Pf development in the mosquito midgut, is a key component of clinical-stage transmission-blocking vaccines. Antibodies against this antigen have been demonstrated to efficiently reduce Pf transmission from humans to mosquitoes. Potent human monoclonal antibodies (mAbs) against Domain 3 (D3) of Pfs48/45 have been structurally and functionally described; however, in-depth information about other inhibitory epitopes on Pfs48/45 is currently limited. Here, we present a 3.3 Å resolution cryo-electron microscopy structure of full-length Pfs48/45 in complex with potent mAbs targeting Domain 1 (D1) and D3, and a moderately potent mAb targeting Domain 2 (D2). Our data indicate that while Pfs48/45 D1 and D2 are rigidly coupled, there is substantial conformational flexibility between D2 and D3. Characterization of mAbs against D1 revealed the presence of a conformational epitope class that is largely conserved across Pf field isolates and is associated with recognition by highly potent antibodies. Our study provides comprehensive insights into epitopes across full-length Pfs48/45 and has implications for the design of next-generation malaria transmission-blocking vaccines and antibodies.

Publisher

Research Square Platform LLC

Reference66 articles.

1. World Health Organization. World malaria report 2021. https://www.who.int/publications-detail-redirect/9789240040496.

2. Malaria Control, Elimination, and Eradication: The Role of the Evolving Biomedical Research Agenda;Hall BF;J. Infect. Dis.,2009

3. Transmission-Blocking Vaccines: Harnessing Herd Immunity for Malaria Elimination;Duffy PE;Expert Rev. Vaccines,2021

4. Current approaches to malaria vaccines;Duffy PE;Curr. Opin. Microbiol.,2022

5. WHO recommends second vaccine for malaria prevention in children;Mahase E;BMJ,2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3